ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

N4P N4 Pharma Plc

0.775
-0.05 (-6.06%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -6.06% 0.775 0.75 0.80 0.825 0.775 0.83 611,345 15:32:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.35 1.39M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.83p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.175p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.39 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.35.

N4 Pharma Share Discussion Threads

Showing 7601 to 7624 of 8600 messages
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older
DateSubjectAuthorDiscuss
09/12/2020
09:11
Looking very interesting after placing Time to buy with so much news on the horizon
hamidahamida
09/12/2020
09:11
Why does he need to, this company proves time and time again that they will screw shareholders. It's a one trick pony that they will keep alive by decimating the share price every 6 months
dplewis1
09/12/2020
09:05
Where is nobbyghome , thought he might show up saying I told you so
charlie888
09/12/2020
09:03
Totally wrong. Best to sell on the spike. Add now, wait for a month and double your money
shirley83
09/12/2020
09:02
WRONG


Ch1rp8 Dec '20 - 14:47 - 4348 of 4360

No cash necessary. Upfront costs and royalties will be paid by potential partners. The world needs a proper vaccine delivery system:)))

purple_helmet
09/12/2020
08:52
YES!!!!!Glad to be part of a business that looks to the future of medicines that will turn the world around:)))
ch1rp
09/12/2020
08:52
Blimey it’s starting to look like nobby had a point
charlie888
09/12/2020
08:44
Got some more at 8.6p
Been a day of shafting by placings
I think I’m gay

volsung
09/12/2020
08:35
Wonder how many free shares or % of the funds raised does Myles get for promoting
this one lol :-))

dave4545
09/12/2020
08:30
OK, 8P then not 6p.
jibba jabber
09/12/2020
08:18
09/12/2020 8:10am

UK Regulatory (RNS & others)


TIDMN4P

RNS Number : 0543I

N4 Pharma PLC

09 December 2020

9 December 2020

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 ("MAR"). In addition, market soundings (as defined in MAR) were taken in respect of the Placing with the result that certain persons became aware of inside information (as defined in MAR), as permitted by MAR. This inside information is set out in this announcement. Therefore, those persons that received inside information in a market sounding are no longer in possession of such inside information relating to the Company and its securities.

N4 Pharma plc

("N4 Pharma" or the "Company")

Placing to raise GBP2 million

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec(R), a novel delivery system for cancer treatments and vaccines, is pleased to announce that it has raised GBP2 million (before expenses) through a placing of 25,000,000 new ordinary shares of 0.4p each in the Company (the "Placing Shares") at an issue price of 8p per Placing Share (the "Placing"). The Placing, which was significantly oversubscribed, was undertaken by share price Angel Corporate Finance LLP.

The net proceeds of the Placing will be used for:

-- the extension of the formulation and current stability work covering DNA and mRNA formulations;


-- research on and evaluation of an additional asset to add to the Company portfolio;
-- business development driven by study results pending over next six months; and
-- ongoing working capital.
Nigel Theobald, Chief Executive of N4 Pharma, commented: "We are delighted with the positive response to our recent formulation work. With vaccines and their delivery very much in the public consciousness we continue to grow our data package to present Nuvec(R) as a viable delivery technology solution to improve the delivery, storage and transportation of multiple existing and new vaccines.

"Whilst we are well funded for all existing work streams these additional funds will enable us to plan for follow on studies and more product focussed experiments as we move towards collaborations."

Application for Admission

The Placing has been conducted utilising the Company's existing share authorities. Application has been made for the Placing Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will take place and that trading will commence on AIM at 8.00 a.m. on or around 14 December 2020. Once issued, the new Ordinary Shares will rank pari passu with the Company's existing ordinary shares.

Total Voting Rights

Following Admission, the enlarged issued share capital of the Company will comprise 181,080,349 Ordinary Shares of 0.4 pence each. The Company does not hold any ordinary shares in treasury. Consequently, 181,080,349 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

jakleeds
09/12/2020
08:18
You have been amrishbhimed. The chancer goes after all spikes, leaving a trail of disaster
purple_helmet
09/12/2020
08:17
purple_helmet8 Dec '20 - 13:49 - 4347 of 4352 Edit
0 2 1
Placing is due, cash is only 2.44m. So careful, could be forward selling in the spike.

purple_helmet
09/12/2020
07:06
There you go, deramping to 6p.
amrishbhim
09/12/2020
07:05
I'm sure if you told people first about your ramping before selling than questioning the motive sounds more like you are deramping this now, I suggest you read what you write
amrishbhim
09/12/2020
07:03
No mate, i'm out for now, 6p target for buy back.
jibba jabber
09/12/2020
06:45
Anyone selling now needs a lobotomy
Jabba you in the back!

saint in exile
08/12/2020
14:47
No cash necessary. Upfront costs and royalties will be paid by potential partners. The world needs a proper vaccine delivery system:)))
ch1rp
08/12/2020
13:49
Placing is due, cash is only 2.44m. So careful, could be forward selling in the spike.
purple_helmet
08/12/2020
09:30
Lol, what a carry on ! You guys are missing the real point here. This share can and will have unbelievable good news from now on. Dyor. This time there is NO deramp:)))
ch1rp
08/12/2020
09:10
I'm not questioning you for your reason but the way you now deramping these shares, I'm sorry you were spiked before, that doesn't mean it going the same direction as before but if it does than it's up to the individual investors to make there mind up, not you! You can't have both pies because it make you a sad person untrustworthy
amrishbhim
08/12/2020
08:53
Only sold because i got spiked first time round and could see it wasn't going to break out past 14. You live and learn and my decision was spot on, if you can't see the same pattern emerging as August then you are deluded. Buy at 6p.
jibba jabber
08/12/2020
08:34
Filtered for being stupid
amrishbhim
08/12/2020
08:26
A few more for me at 10.18p
volsung
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older

Your Recent History

Delayed Upgrade Clock